Artikaiini 40mg ja kloroprokaiini 40 mg päiväkirurgisina spinaalipuudutteina(Lyhenne: A40C40) - A40C40

• Conditions: Knee arthroscopy performed as day case surgery; MedDRA version: 12.1Level: LLTClassification code 10054948Term: Meniscus operation

• Registration Number: EUCTR2011-000062-35-FI
• Lead Sponsor: Mikko Pitkänen, MD, PhD

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01-18
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Age 18 - 70 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Body mass index > 36 kg/m2

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: The purpose of the study is to compare singel doses of articaine 40 mg and chloroprocaine 40 mg as spinal anesthetics in patients scheduled for ambulatory knee arthroscopy. The null hypothesis is that there will be reliable and sufficient spinal anesthesia in both study groups combined with no differences between the study groups as regards recovery from spinal anesthesia (main outcome parameter: recovery from motor blockade).;Secondary Objective: ;Primary end point(s): Recovery from spinal anesthesia (particularly from motor blockade)